← Browse by Condition
Medical Condition
neovascular age related macular degeneration
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3
NCT06847542 Phase 3
Recruiting
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Enrollment
250 pts
Location
Austria, Czechia, De...
Sponsor
Hoffmann-La Roche
NCT05562947 Phase 3
Recruiting
A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)
Enrollment
68 pts
Location
China
Sponsor
Hoffmann-La Roche
NCT06680817
Recruiting
A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)
Enrollment
850 pts
Location
Austria, Bulgaria, C...
Sponsor
Hoffmann-La Roche